Hyperoxia impairs postnatal alveolar epithelial development via NADPH oxidase in newborn mice

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L134-42. doi: 10.1152/ajplung.00112.2009. Epub 2009 May 1.

Abstract

Hyperoxia disrupts postnatal lung development in part through inducing inflammation. To determine the contribution of leukocyte-derived reactive oxygen species, we exposed newborn wild-type and NADPH oxidase p47(phox) subunit null (p47(phox-/-)) mice to air or acute hyperoxia (95% O(2)) for up to 11 days. Hyperoxia-induced pulmonary neutrophil influx was similar in wild-type and p47(-/-) mice at postnatal days (P) 7 and 11. Macrophages were decreased in wild-type hyperoxia-exposed mice compared with p47(phox-/-) mice at P11. Hyperoxia impaired type II alveolar epithelial cell and bronchiolar epithelial cell proliferation, but depression of type II cell proliferation was significantly less in p47(-/-) mice at P3 and P7, when inflammation was minimal. We found reciprocal results for the expression of the cell cycle inhibitor p21(cip/waf) in type II cells, which was induced in 95% O(2)-exposed wild-type mice, but significantly less in p47(phox-/-) littermates at P7. Despite partial preservation of type II cell proliferation, deletion of p47(phox) did not prevent the major adverse effects of hyperoxia on alveolar development estimated by morphometry at P11, but hyperoxia impairment of elastin deposition at alveolar septal crests was significantly worse in wild-type vs. p47(phox-/-) mice at P11. Since we found that p47(phox) is expressed in a subset of alveolar epithelial cells, its deletion may protect postnatal type II alveolar epithelial proliferation from hyperoxia through effects on epithelial as well as phagocyte-generated superoxide.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects
  • Aging / pathology
  • Air
  • Animals
  • Animals, Newborn
  • Body Weight / drug effects
  • Bronchoalveolar Lavage Fluid
  • Cell Proliferation / drug effects
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology*
  • Epithelial Cells / pathology*
  • Gene Deletion
  • Hyperoxia / enzymology*
  • Hyperoxia / pathology*
  • Mice
  • NADPH Oxidases / metabolism*
  • Oxygen / pharmacology
  • Pneumonia / enzymology
  • Pneumonia / pathology
  • Protein Transport / drug effects
  • Pulmonary Alveoli / drug effects
  • Pulmonary Alveoli / enzymology*
  • Pulmonary Alveoli / growth & development
  • Pulmonary Alveoli / pathology*
  • Pulmonary Surfactant-Associated Protein C / metabolism
  • Survival Analysis
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism

Substances

  • Cyclin-Dependent Kinase Inhibitor p21
  • Pulmonary Surfactant-Associated Protein C
  • 3-nitrotyrosine
  • Tyrosine
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Oxygen